Nicole Germino
Stock Analyst at Truist Securities
(1.88)
# 1275
Out of 5,368 analysts
30
Total ratings
58.33%
Success rate
24.62%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
YMAB Y-mAbs Therapeutics | Maintains: Buy | 18 14 | 4.73 | 195.98% | 3 | May 14, 2025 | |
CATX Perspective Therapeu... | Maintains: Buy | 10 8 | 3.17 | 152.37% | 3 | May 14, 2025 | |
INSM Insmed | Maintains: Strong Buy | 105 108 | 98.8 | 9.31% | 8 | Feb 21, 2025 | |
SGMO Sangamo Therapeutics | Maintains: Buy | 7 5 | n/a | n/a | 5 | Jan 23, 2025 | |
FUSN Fusion Pharmaceutica... | Downgrades: Hold | 11 21 | n/a | n/a | 3 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 13 13 | n/a | n/a | 3 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 132 24 | 16.86 | 42.35% | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Sep 3, 2021 |